751 related articles for article (PubMed ID: 29783802)
21. Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer.
Tomoda C; Miyauchi A; Uruno T; Takamura Y; Ito Y; Miya A; Kobayashi K; Matsuzuka F; Kuma S; Kuma K; Kakudo K
World J Surg; 2004 Sep; 28(9):886-9. PubMed ID: 15593462
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of cribriform morular variant of papillary thyroid carcinoma in post-Chernobyl affected region.
Lam AK; Fridman M
Hum Pathol; 2018 Apr; 74():170-177. PubMed ID: 29320754
[TBL] [Abstract][Full Text] [Related]
23. Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior.
Cameselle-Teijeiro J; Menasce LP; Yap BK; Colaco RJ; Castro P; Celestino R; Ruíz-Ponte C; Soares P; Sobrinho-Simões M
Am J Clin Pathol; 2009 Jan; 131(1):134-42. PubMed ID: 19095577
[TBL] [Abstract][Full Text] [Related]
24. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
25. The cytological, clinical, and pathological features of the cribriform-morular variant of papillary thyroid carcinoma and mutation analysis of CTNNB1 and BRAF genes.
Jung CK; Choi YJ; Lee KY; Bae JS; Kim HJ; Yoon SK; Son YI; Chung JH; Oh YL
Thyroid; 2009 Aug; 19(8):905-13. PubMed ID: 19534622
[TBL] [Abstract][Full Text] [Related]
26. TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.
Oh EJ; Lee S; Bae JS; Kim Y; Jeon S; Jung CK
Endocr Pathol; 2017 Mar; 28(1):49-53. PubMed ID: 27688081
[TBL] [Abstract][Full Text] [Related]
27. Cribriform-morular variant of papillary thyroid carcinoma in an 8-year-old girl: a case report with immunohistochemical and molecular testing.
Rossi ED; Revelli L; Martini M; Taddei A; Pintus C; Panunzi C; Fadda G
Int J Surg Pathol; 2012 Dec; 20(6):629-32. PubMed ID: 22494995
[TBL] [Abstract][Full Text] [Related]
28. Cribriform-morular variant of papillary thyroid carcinoma: ultrastructural study and somatic/germline mutation analysis of the APC gene.
Kameyama K; Mukai M; Takami H; Ito K
Ultrastruct Pathol; 2004; 28(2):97-102. PubMed ID: 15205109
[TBL] [Abstract][Full Text] [Related]
29. Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an
Ito Y; Ishikawa H; Kihara M; Hirokawa M; Kiyota N; Kasahara T; Miyauchi A
Thyroid; 2019 Oct; 29(10):1511-1517. PubMed ID: 31317827
[No Abstract] [Full Text] [Related]
30. Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases.
Akaishi J; Kondo T; Sugino K; Ogimi Y; Masaki C; Hames KY; Yabuta T; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Katoh R; Ito K
World J Surg; 2018 Nov; 42(11):3616-3623. PubMed ID: 29696324
[TBL] [Abstract][Full Text] [Related]
31. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
32. Age- and Gender-Specific Risk of Thyroid Cancer in Patients With Familial Adenomatous Polyposis.
Uchino S; Ishikawa H; Miyauchi A; Hirokawa M; Noguchi S; Ushiama M; Yoshida T; Michikura M; Sugano K; Sakai T
J Clin Endocrinol Metab; 2016 Dec; 101(12):4611-4617. PubMed ID: 27623068
[TBL] [Abstract][Full Text] [Related]
33. Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Corean J; Furtado LV; Kadri S; Segal JP; Emerson LL
Int J Surg Pathol; 2019 May; 27(3):294-304. PubMed ID: 30176755
[TBL] [Abstract][Full Text] [Related]
34. Cytologic characteristics and β-catenin immunocytochemistry on smear slide of cribriform-morular variant of papillary thyroid carcinoma.
Koo JS; Jung W; Hong SW
Acta Cytol; 2011; 55(1):13-8. PubMed ID: 21135516
[TBL] [Abstract][Full Text] [Related]
35. Cribriform morular variant of papillary thyroid carcinoma: Cytomorphology, differential diagnosis and diagnostic implications in patients with adenomatous polyposis coli.
Priyani AA; Opatha ST; Gunathilake NW; Lokuhetty MD
J Cytol; 2016; 33(4):235-238. PubMed ID: 28028343
[TBL] [Abstract][Full Text] [Related]
36. Cribriform-morular variant of papillary thyroid carcinoma: ultrasonographic and clinical characteristics.
Chong Y; Shin JH; Oh YL; Han BK; Ko EY
Thyroid; 2013 Jan; 23(1):45-9. PubMed ID: 22892017
[TBL] [Abstract][Full Text] [Related]
37. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
Paek SH; Kim BS; Kang KH; Kim HS
World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
[TBL] [Abstract][Full Text] [Related]
38. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
39. LEF-1 is a Sensitive Marker of Cribriform Morular Variant of Papillary Thyroid Carcinoma.
Mohindra S; Sakr H; Sturgis C; Chute DJ
Head Neck Pathol; 2018 Dec; 12(4):455-462. PubMed ID: 29243023
[TBL] [Abstract][Full Text] [Related]
40. Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.
Levy RA; Hui VW; Sood R; Fish S; Markowitz AJ; Wong RJ; Guillem JG
Fam Cancer; 2014 Dec; 13(4):547-51. PubMed ID: 24934245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
